Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin with Palliative Radiotherapy in Cervical Cancer
NCT05947513Recruiting
- Sponsor
- Addis Ababa University
- Start
- Apr 2025
- Primary completion
- Feb 2026
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of curcumin in Cervical Cancer (CC), sponsored by Addis Ababa University. Primary endpoints: Treatment Fidelity Rate and Objective Response Rate. Started Apr 2025; status: recruiting.
02
Drugs
curcumin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT05947513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05947513.